Disequilibria in the distribution of rpoB alleles in rifampicin- resistant M. tuberculosis isolates from Germany and Sierra Leone

Microbial Drug Resistance

Volumn 3, Issue 2, 1997, Pages 195-198

  Rinder, Heinz ^a,e   Dobner, Petra ^a   Feldmann, Knut ^b   Rifai, Mohammed ^b   Bretzel, Gisela ^c   Rüsch Gerdes, Sabine ^d   Löscher, Thomas ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b ASKLEPIOS FACHKLINIKEN MÜNCHEN GAUTING   (Germany)

^c Klinikum der Ludwig Maximilians Universität München   (Germany)

^d RESEARCH CENTER BORSTEL   (Germany)

^e Department of Infectious Diseases and Tropical Medicine ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RIFAMPICIN;

ALLELE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; DNA SEQUENCE; GENE; GENE MUTATION; GENE SEQUENCE; GERMANY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; SIERRA LEONE; TUBERCULOSIS;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0030939777     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.1997.3.195     Document Type: Article

References (11)

1. Bodmer, T., G. Zürcher, P. Imboden, and A. Telenti. 1995. Mutation position and type of substitution in the β-subunit of the RNA polymerase influence in vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis. J. Antimicrob. Chemother. 35:345-348.
2. Caugant, D.A., P. Sandven, J. Eng, J.T. Jeque, and T. Tonjum. 1995. Detection of rifampin resistance among isolates of Mycobacterium tuberculosis from Mozambique. Microb. Drug Resist. 1:321-326.
3. Godfrey-Faussett, P., N.G. Stoker, J.A.G. Scott, G. Pasvol, P. Kelly, and L. Clancy. 1993. DNA fingerprints of Mycobacterium tuberculosis do not change during the development of rifampicin resistance. Tubercle Lung Dis. 74:240-243.
4. Heym, B., N. Honoré, C. Truffot-Pernot, A. Banerjee, C. Schurra, W.R. Jacobs, J.D.A. van Embden, J.H. Grosset, and S.T. Cole. 1994. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: A molecular study. Lancet 344:293-298.
5. Kapur, V., L.L. Li, S. Iordanescu, M.R. Hamrick, A. Wanger, B.N. Kreiswirth, and J.M. Musser 1994. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase β subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J. Clin. Microbiol. 32:1095-1098.
6. Ohno, H., H. Koga, S. Kohno, T. Tashiro, and K. Hara. 1996. Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob. Agents Chemother. 40:1053-1056.
7. Telenti, A., P. Imboden, F. Marchesi, D. Lowrie, S. Cole, M.J. Colston, L. Matter, L. Schopfer, and T. Bodmer. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650.
8. Tsukamura, M. 1972. The pattern of resistance development to rifampicin in Mycobacterium tuberculosis. Tubercle 53:111-117.
9. Whelen, A.C., T.A. Felmlee, J.M. Hunt, D.L. Williams, G.D. Roberts, L. Stockman, and D.H. Persing. 1995. Direct genotypic detection of Mycobacterium tuberculosis rifampin resistance in clinical specimens by using single-tube heminested PCR. J. Clin. Microbiol. 33:556-561.
10. Williams, D.L., C. Waguespack, K. Eisenach, J.T. Crawford, F. Portaels, M. Salfinger, C.M. Nolan, C. Abe, V. Sticht-Groh, and T.P. Gillis. 1994. Characterization of rifampin resistance in pathogenic mycobacteria. Antimicrob. Agents Chemother. 38:2380-2386.
11. Yamada, T., A. Nagata, Y. Ono, Y. Suzuki, and T. Yamanouchi. 1985. Alteration of ribosomes and RNA polymerase in drug-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 27:921-924.